Skip to main content
. 2014 Jan 8;25(3):611–618. doi: 10.1093/annonc/mdt556

Figure 2.

Figure 2.

Prognostic value of high lymphocytic infiltration on residual disease after neoadjuvant chemotherapy. Estimated Kaplan–Meyer curves of metastasis-free survival (A) and overall survival (B) for all patients. Estimated Kaplan–Meyer curves of metastasis-free survival for patients with node-negative and ≤2 cm residual disease (C) and for patients with node-positive and/or >2 cm residual disease (D).